“This technology meets a significant need for solutions to prosthetic joint infections that risk the mobility of our growing aging population.”James Y. Lancaster, CEO of Solenic Medical, Inc.
COLLEGE STATION, Texas (PRWEB)
July 30, 2020
Solenic Medical, a developer of a device that uses alternating magnetic fields to treat a prosthetic joint infections (PJI) announced today that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). Breakthrough Designation is reserved for devices or technologies that may provide for more effective treatment of life-threatening or irreversibly debilitating conditions in order